Tag: Immunotherapeutics
SIRPant Immunotherapeutics Appoints Jelle Kijlstra, MD, MBA as Chief Medical Off…...
Accomplished healthcare executive brings extensive drug development and regulatory experience from global CRO and multiple pharmaceutical companies to SIRPant Immunotherapeutics Inc
SIRPant Immunotherapeutics Inc,...
OSE Immunotherapeutics Presents Update on BiCKI®IL-7, CLEC-1 and OSE-230 Preclin… –...
Regulatory News:
OSE Immunotherapeutics SA FR presents scientific updates in oral and poster presentations selected for international conferences: at the Antibody Engineering & Therapeutics...
OSE Immunotherapeutics Presents Clinical Abstracts on Tedopi® at the ASCO 2023...
Tedopi® is the Company's Most Advanced Product in Clinical Development
ATALANTE-1, a Phase 3 clinical trial with positive results comparing Tedopi® to chemotherapy in...
Boehringer Ingelheim and OSE Immunotherapeutics To Present Biomarker Analyses fr… –...
At American Association for Cancer...